Cours Cantabio Pharmaceuticals, Inc.
Actions
CTBO
US13808X2036
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,01 USD | -95,96% | -.--% | -.--% |
CA 2017 | - | CA 2018 | - | Capitalisation | 2,36 M 2,15 M |
---|---|---|---|---|---|
Résultat net 2017 | -1 M -910 k | Résultat net 2018 | -2 M -1,82 M | VE / CA 2017 | - |
Dette nette 2017 | 337 k 307 k | Dette nette 2018 | 1,1 M 997 k | VE / CA 2018 | - |
PER 2017 * |
-
| PER 2018 |
-
| Employés | - |
Rendement 2017 * |
-
| Rendement 2018 |
-
| Flottant | 29,99% |
1 jour | -95,96% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/05/15 |
Gergely Tóth
FOU | Founder | 51 | 06/02/12 |
Max Zhu
BRD | Director/Board Member | 42 | 01/01/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
-.--% | 24,35 k | |
+41,79% | 50,93 Md | |
-0,56% | 42,12 Md | |
+49,62% | 42,05 Md | |
-7,20% | 29,18 Md | |
+12,59% | 26,02 Md | |
-21,51% | 18,9 Md | |
+6,92% | 13,21 Md | |
+24,91% | 12,17 Md | |
+29,60% | 12,16 Md |